FY2025 · ended Dec 28, 2025 · Revenue $4.34B, -0.7% YoY · Filed Feb 12, 2026
Illumina, Inc. (ILMN) files with the SEC under industry code 3826, Laboratory Analytical Instruments. In fiscal 2025, which ended Dec 28, 2025, it reported revenue of $4.3 billion and net income of $850.0 million. Free cash flow was $931.0 million. As of Sep 27, 2026 it held $1.3 billion in cash and investments and $524.0 million in total debt.
Revenue (TTM)
$4.54B
+5.9% vs year-ago TTM
Net income (TTM)
$895.00M
+27.3% vs year-ago TTM
Operating cash flow (TTM)
$1.23B
+9.6% vs year-ago TTM
Free cash flow (TTM)
$1.06B
+5.7% vs year-ago TTM
EPS (TTM)
$5.82
+30.4% vs year-ago TTM
Dividend per share
None
Shares outstanding
152.90M
-3.5% vs prior year
Net cash
$813.00M
as of Sep 27, 2026
Operating margin
21.2%
FY 2026
Company profile
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Listed as
- ILMN (Nasdaq)
- Fiscal year ends
- January 3
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1110803
- Former names
- ILLUMINA INC (until Aug 19, 2019)
Other Laboratory Analytical Instruments companies
- Agilent Technologies, Inc. A
- Waters Corp /DE/ WAT
- Mettler Toledo International INC/ MTD
- Revvity, Inc. RVTY
- Avantor, Inc. AVTR
- Bio-Rad Laboratories, Inc. BIO
- Bruker Corp BRKR
- 10x Genomics, Inc. TXG
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 28, 2025 |
FY 2024 Dec 29, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Jan 1, 2023 |
FY 2021 Jan 2, 2022 |
|---|---|---|---|---|---|
| Revenue | $4.3B | $4.4B | $4.5B | $4.6B | $4.5B |
| Operating income | $807.0M | -$833.0M | -$1.1B | -$4.2B | -$123.0M |
| Net income | $850.0M | -$1.2B | -$1.2B | — | $762.0M |
| Diluted EPS | $5.45 | -$7.69 | -$7.34 | -$28.00 | $5.04 |
| Operating cash flow | $1.1B | $837.0M | $478.0M | $392.0M | $545.0M |
| Free cash flow | $931.0M | $709.0M | $283.0M | $106.0M | $337.0M |
| Total assets | $6.6B | $6.3B | $10.1B | $12.3B | $15.2B |
| Stockholders' equity | $2.7B | $2.4B | $5.7B | $6.6B | — |
| Cash and investments | $1.6B | $1.2B | $1.1B | $2.0B | $1.3B |
| Total debt | $564.0M | $633.0M | $773.0M | $820.0M | $845.0M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 30, 2026 | Sep 27, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Oct 13, 2026 | Oct 13, 2026 |
| 8-K |
Current report
Other events
|
Aug 17, 2026 | Aug 17, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Other events
|
Aug 12, 2026 | Aug 10, 2026 |
All 1003 Illumina, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.